Table 1 Clinical characteristics of the study patients
From: State-of-the-art monitoring in treatment of dengue shock syndrome: a case series
Characteristic | Case 1 patient | Case 2 patient | Case 3 patient |
|---|---|---|---|
Age (years) | 7 | 7 | 9 |
Gender | M | M | M |
Clinical diagnosis | DHF grade III | DHF grade III | DHF grade III |
RT-PCR | DENV-2 | DENV-2 | DENV-2 |
Serologic response | Secondary | Secondary | Secondary |
Fever day at admission | 0 | –1 | 0 |
Percent hemoconcentration | 28 | 44 | 39 |
Pleural effusion index | 41 | 66 | 26 |
Clinical evidence of shock | |||
Systolic BP <80 mmHg | N | Y | N |
Pulse pressure <20 mmHg | Y | Y | Y |
Cold extremities | Y | Y | Y |
Minimum systolic BP (mmHg) | |||
Study day 1 | 97 | 74 | 97 |
Study day 2 | 96 | 87 | 93 |
Minimum pulse pressure (mmHg) | |||
Study day 1 | 26 | 15 | 29 |
Study day 2 | 18 | 15 | 15 |
Fluid intake (ml/kg) | |||
Study day 1 | 46 | 63 | 25 |
Study day 2 | 53 | 100 | 86 |
Study day 3 | 30 | 20 | 46 |
Study day 4 | 21 | 20 | 35 |
Transfusion (ml/kg) | 4.9 (study day 1) | None | None |
Other findings | Ascites, upper GI bleeding | Ascites | Ascites, hemoconcentration, petechiae |
Length of hospital stay, days | 6 | 5 | 5 |